Radha Gopalaswamy

Employment

• National Institute of Research in Tuberculosis Biotechnologist - National Reference Laboratory, National Tuberculosis Elimination Program
  2020 - Present
• National Institute of Research in Tuberculosis Scientist - Chennai Cambridge collaborative study
  2017 - 2019
• Orchid Pharma Ltd Scientist - In vitro Assay Development
  2009 - 2017
• University of British Columbia Post doctoral Researcher
  2006 - 2008

Education

• National Institute of Research in Tuberculosis Ph D (Immunology/ Molecular Biology/Bio-Medical Genetics)
  2000 - 2006
• University of Madras - Institute of Basic Medical Sciences M. Sc Bio-Medical Genetics
  1998 - 2000
• Justice Basheer Ahmed Sayeed College for Women B. Sc Zoology
  1995 - 1998

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Distribution of Non-Tuberculous Mycobacterium Species in Pulmonary and Extrapulmonary Infections in South India–A Retrospective Analysis
  Microorganisms 2026 DOI: 10.3390/microorganisms14061319
  +Save
• Erratum for Gopalaswamy and Subbian, “The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management”
  Clinical Microbiology Reviews 2026 DOI: 10.1128/cmr.00093-26
  +Save
• The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management
  Clinical Microbiology Reviews 2026 DOI: 10.1128/cmr.00194-25
  +Save
• Pilot evaluation of a compact targeted next-generation sequencing with minimum biocontainment for rapid diagnosis of drug-resistant tuberculosis
  Microbiology Spectrum 2026 DOI: 10.1128/spectrum.02917-25
  +Save
• Intricacies of Global Tuberculosis Management—EndTB-2035 on the Fence?
  Journal of Respiration 2025 DOI: 10.3390/jor5010004
  +Save
• Direct targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis from clinical samples – An update
  Indian Journal of Tuberculosis 2025 DOI: 10.1016/j.ijtb.2025.02.019
  +Save
• The Ambivalence of Post COVID-19 Vaccination Responses in Humans
  Biomolecules 2024 DOI: 10.3390/biom14101320
  +Save
• Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India
  Frontiers in Public Health 2023 DOI: 10.3389/fpubh.2023.1255756
  +Save
• Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India
  Medicina 2023 DOI: 10.3390/medicina59061005
  +Save
• An odyssey from laboratory to field ? – Portable tNGS system for TB diagnosis in programmatic setting
  Indian Journal of Tuberculosis 2022 DOI: 10.1016/j.ijtb.2022.04.004
  +Save